AUROBINDO PHARMA LTD has received final US FDA approval to #manufacture and market Rivaroxaban Tablets USP, 2.5 mg, the generic equivalent of XARELTO (2.5 mg). The company plans to launch it in Q1 FY26. It also received tentative approval for 10 mg, 15 mg, and 20 mg strengths. #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/gza2Htep
